Europe Insulin Drugs Market Share

Statistics for the 2023 & 2024 Europe Insulin Drugs market share, created by Mordor Intelligence™ Industry Reports. Europe Insulin Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Europe Insulin Drugs Industry

The European insulin drug market is highly consolidated in nature due to the presence of only a few major companies operating globally as well as regionally. Mergers and acquisitions between players in the recent past have helped companies strengthen their market presence. Eli Lilly and Boehringer Ingelheim have an alliance to develop and commercialize Abasaglar (Insulin Glargine).

Europe Insulin Drugs Market Leaders

  1. Novo Nordisk

  2. Sanofi

  3. Eli Lilly

  4. AstraZeneca

  5. Biocon

*Disclaimer: Major Players sorted in no particular order

Europe Insulin Drugs Market Concentration

Europe Insulin Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)